These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 27609187

  • 1. Alpha-2 agonists for sedation in mechanically ventilated neurocritical care patients: a systematic review protocol.
    Tran A, Blinder H, Hutton B, English S.
    Syst Rev; 2016 Sep 08; 5(1):154. PubMed ID: 27609187
    [Abstract] [Full Text] [Related]

  • 2. A Systematic Review of Alpha-2 Agonists for Sedation in Mechanically Ventilated Neurocritical Care Patients.
    Tran A, Blinder H, Hutton B, English SW.
    Neurocrit Care; 2018 Feb 08; 28(1):12-25. PubMed ID: 28547318
    [Abstract] [Full Text] [Related]

  • 3. Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients.
    Chen K, Lu Z, Xin YC, Cai Y, Chen Y, Pan SM.
    Cochrane Database Syst Rev; 2015 Jan 06; 1(1):CD010269. PubMed ID: 25879090
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clonidine for sedation in the critically ill: a systematic review and meta-analysis (protocol).
    Jing Wang G, Belley-Coté E, Burry L, Duffett M, Karachi T, Perri D, Alhazzani W, D'Aragon F, Wunsch H, Rochwerg B.
    Syst Rev; 2015 Nov 06; 4():154. PubMed ID: 26542363
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK.
    Walsh TS, Aitken LM, McKenzie CA, Boyd J, Macdonald A, Giddings A, Hope D, Norrie J, Weir C, Parker RA, Lone NI, Emerson L, Kydonaki K, Creagh-Brown B, Morris S, McAuley DF, Dark P, Wise MP, Gordon AC, Perkins G, Reade M, Blackwood B, MacLullich A, Glen R, Page VJ.
    BMJ Open; 2023 Dec 10; 13(12):e078645. PubMed ID: 38072483
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
    Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG, SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group.
    JAMA; 2009 Feb 04; 301(5):489-99. PubMed ID: 19188334
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of sedation strategies for critically ill patients: a protocol for a systematic review incorporating network meta-analyses.
    Hutton B, Burry LD, Kanji S, Mehta S, Guenette M, Martin CM, Fergusson DA, Adhikari NK, Egerod I, Williamson D, Straus S, Moher D, Ely EW, Rose L.
    Syst Rev; 2016 Sep 20; 5(1):157. PubMed ID: 27646881
    [Abstract] [Full Text] [Related]

  • 15. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions.
    Venn RM, Grounds RM.
    Br J Anaesth; 2001 Nov 20; 87(5):684-90. PubMed ID: 11878517
    [Abstract] [Full Text] [Related]

  • 16. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation.
    Hoy SM, Keating GM.
    Drugs; 2011 Jul 30; 71(11):1481-501. PubMed ID: 21812509
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reconsidering Dexmedetomidine for Sedation in the Critically Ill: Implications of the SPICE III Trial.
    Farina N, Alaniz C.
    Ann Pharmacother; 2020 May 30; 54(5):504-508. PubMed ID: 31744312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.